1Zhang W,oherty M. EULAR recommendations for knee and hip osteoarthritis:acritique of the methodology[ J ]. Br J Sports Med,2006, 40 ( 8 ) :664- 669. 被引量：1
3Westacott CI, Sharif M. Cytokines in osteoarthritis: mediators or markers of joint destruction? [ J ]. Semin Arthritis Rheum, 1996, 25(4) :254-272. 被引量：1
4Kammermann JR, Kincaid SA, Rumph PF, et, al. Tumor necrosis facfor - alpha( TNF - alpha ) in canine osteoarthritis : lmmunolocalization of TNF - alpha,strometysin and TNF receptors in canine osteoarthritic cartilage [ J ]. Osteoarthritis Cartilage, 1996,4 ( 1 ) :23- 34. 被引量：1
5Date H, Yamada H, Kanaji A,et,al. Absolute risk for fracture and WHO guideline. Biological markers for osteoarthritis (OA) [ J ]. C linicalCalcium, 2007,17 ( 7 ) : 1071 - 1079. 被引量：1
6Dougados M, Nguyen M, Berdahl, et al. Evaluation of the structure - modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three - year, placebo - controled trial. Evaluation of the chondromodulating. Effect of diacerein in OA of the hip [ J ]. Arthritis Rheum ,2001,44( 11 ) :2539- 2547. 被引量：1
二级参考文献23
1Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum, 2000, 43: 1905-1915. 被引量：1
2Schnitzer TJ, American College of Rheumatology. Update of ACR guidelines for osteoarthritis: role of the coxibs. J Pain Symptom Manage, 2002, 23(4 Suppl): S24-34. 被引量：1
3Hochberg MC, Ahman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis. Part Ⅱ. Osteoarthritis of the knee. American College of Rheumatology. Arthritis Rheum, 1995, 38:1541-1546. 被引量：1
4Hochberg MC, Ahman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis. Part Ⅰ. Osteoarthritis of the hip. American College of Rheumatology. Arthritis Rheum, 1995, 38: 1535-1540. 被引量：1
5Simon LS, Lipman AG, Jacox AK, eds. Pain in osteoarthritis, rheumatoid arthritis and juvenile chronic arthritis. 2nd ed. Glenview (IL): American Pain Society (APS), 2002. 179. 被引量：1
6Zhang W, Doherty M, Leeb BF, et al. EULAR evidence based recommendations for the management of hand osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis, 2007, 66: 377-388. 被引量：1
7Zhang W, Doherty M. EULAR recommendations for knee and hip osteoarthritis: a critique of the methodology. Br J Sports Med, 2006, 40: 664-669. 被引量：1
8Pendleton A, Arden N, Dougados M, et al. EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis, 2000, 59: 936-944. 被引量：1
9Zhang W, Doherty M, Arden N, et al. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis, 2005, 64: 669-681. 被引量：1
10Chevalier X, Marre JP, de Butler J, et al. Questionnaire survey of management and prescription of general practitioners in knee osteoarthritis: a comparison with 2000 EULAR recommendations. Clin Exp Rheumatol, 2004, 22: 205-212. 被引量：1
